UVB-induced decrease of p16/CDKN2A expression in skin cancer patients

Related Experiment Video

Updated: Oct 5, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

G Krähn1, U Leiter, M Udart

  • 1Department of Dermatology, University of Munich, Germany. ulrike.leiter@medizin.uni-ulm.de

Pigment Cell Research
|July 4, 2001
PubMed

Insights

UVB exposure down-regulates p16/CDKN2A gene expression in skin cancer patients, unlike healthy individuals. This decline in p16/CDKN2A may impair cell cycle regulation, offering insights into UV-induced skin cancer development.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Cancer Research

Background:

  • p16 expression in melanoma tissues is contradictory.
  • Ultraviolet (UV) radiation, including UVB, impacts p16 expression and cell cycle regulation.
  • p16/CDKN2A is a key tumor suppressor gene involved in cell cycle control.

Purpose of the Study:

  • To investigate the effect of UVB exposure on p16/CDKN2A gene expression in skin cancer patients and healthy individuals.
  • To explore the role of p16/CDKN2A down-regulation in UV-induced skin carcinogenesis.

Main Methods:

  • Reverse transcription polymerase chain reaction (RT-PCR) was used to quantify p16/CDKN2A gene expression.
  • Participants included skin cancer patients, a dysplastic nevus patient, and healthy controls.
  • Samples were analyzed before and after controlled UVB exposure (one minimal erythema dose).

Main Results:

  • Five out of seven skin cancer patients exhibited down-regulation of p16/CDKN2A expression post-UVB exposure.
  • Healthy individuals and the dysplastic nevus patient showed no significant alteration in p16/CDKN2A expression after UVB.
  • UVB-induced decline in p16/CDKN2A was observed specifically in skin cancer patients.

Conclusions:

  • UVB-induced down-regulation of p16/CDKN2A in skin cancer patients suggests a potential mechanism in photocarcinogenesis.
  • Impaired cell cycle regulation due to decreased p16/CDKN2A may contribute to skin cancer development.
  • Altered p16/CDKN2A expression patterns after UVB exposure could serve as a biomarker for identifying individuals at higher risk of UV-induced skin cancer.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Studying Chronic Exposure of Mice to Ultraviolet B Radiation03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...